MedTrace Logo

Minocycline for Treatment of Posttraumatic Stress Disorder in Veterans

NCT03340350 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2020-07-09

Study results available
· View outcomes & findings →

Summary

The study will evaluate the safety and efficacy of adjunctive minocycline treatment in veterans with PTSD.

Conditions

Interventions

DRUG

Minocycline

Minocycline capsule

Sponsors & Collaborators

  • Creighton University

    collaborator OTHER

  • Sriram Ramaswamy

    lead FED

Principal Investigators

  • Sriram Ramaswamy, MD · VA Nebraska Western Iowa Health Care System

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-10
Primary Completion
2018-06-01
Completion
2018-06-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03340350 on ClinicalTrials.gov